Comments on: Pulmonary Function and Diffusing Capacity of Carbon Monoxide in Hypersensitivity Pneumonitis: An Observational Study of 152 Patients.
作者信息
Mehta Kundan Nikit, Ramnani Hiral Gulab
机构信息
Department of Respiratory Medicine, Institute of Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India.
出版信息
Thorac Res Pract. 2024 Sep 2;25(5):193-194. doi: 10.5152/ThoracResPract.2024.24036.
Abstract
摘要
相似文献
1
Comments on: Pulmonary Function and Diffusing Capacity of Carbon Monoxide in Hypersensitivity Pneumonitis: An Observational Study of 152 Patients.
Thorac Res Pract. 2024 Sep 2;25(5):193-194. doi: 10.5152/ThoracResPract.2024.24036.
2
RE: Comment on: Pulmonary Function and Diffusing Capacity of Carbon Monoxide in Hypersensitivity Pneumonitis: An Observational Study of 152 Patients.
Thorac Res Pract. 2024 Sep 2;25(5):195-196. doi: 10.5152/ThoracResPract.2024.240362.
3
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohort.
J Scleroderma Relat Disord. 2018 Oct;3(3):237-241. doi: 10.1177/2397198318778818. Epub 2018 Jun 1.
4
Pulmonary Function and Diffusing Capacity of Carbon Monoxide in Hypersensitivity Pneumonitis: An Observational Study of 152 Patients.
Thorac Res Pract. 2024 Mar;25(2):51-56. doi: 10.5152/ThoracResPract.2024.23038.
5
A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis.
Eur Respir J. 2014 Aug;44(2):415-24. doi: 10.1183/09031936.00010414. Epub 2014 Apr 17.
6
Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise.
N Engl J Med. 1987 May 21;316(21):1301-6. doi: 10.1056/NEJM198705213162103.
7
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.
Am J Med. 1984 Dec;77(6):1027-34. doi: 10.1016/0002-9343(84)90183-9.
8
Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID-19: A prospective cohort study (the SECURe study).
Exp Physiol. 2024 May;109(5):652-661. doi: 10.1113/EP091757. Epub 2024 Mar 26.
9
Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis.
Eur Respir J. 2014 Dec;44(6):1658-65. doi: 10.1183/09031936.00060714. Epub 2014 Aug 19.
10
General aspects of hypersensitivity pneumonitis in Turkey.
Tuberk Toraks. 2010;58(3):242-51.
本文引用的文献
1
Pulmonary Function and Diffusing Capacity of Carbon Monoxide in Hypersensitivity Pneumonitis: An Observational Study of 152 Patients.
Thorac Res Pract. 2024 Mar;25(2):51-56. doi: 10.5152/ThoracResPract.2024.23038.
2
Erratum: Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2021 Jan 1;203(1):150-151. doi: 10.1164/rccm.v203erratum1.
3
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
4
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
5
Combined pulmonary fibrosis and emphysema syndrome: a review.
Chest. 2012 Jan;141(1):222-231. doi: 10.1378/chest.11-1062.
6
Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis.
J Allergy Clin Immunol. 1989 Nov;84(5 Pt 2):839-44. doi: 10.1016/0091-6749(89)90349-7.
Zotero 插件